Lesion-Based Radiomics Signature in Pretherapy 18F-FDG PET Predicts Treatment Response to Ibrutinib in Lymphoma.
Jimenez JE, Dai D, Xu G, Zhao R, Li T, Pan T, Wang L, Lin Y, Wang Z, Jaffray D, Hazle JD, Macapinlac HA, Wu J, Lu Y.
Jimenez JE, et al. Among authors: li t.
Clin Nucl Med. 2022 Mar 1;47(3):209-218. doi: 10.1097/RLU.0000000000004060.
Clin Nucl Med. 2022.
PMID: 35020640
Free PMC article.